Perawatan Kanker lambung di Israel — dapatkan 3 kecocokan klinik pribadi

Dr. Pelles Sharon memimpin layanan tumor sistem pencernaan di Sourasky Medical Center – dilatih di Royal Marsden Cancer Centre London di bawah Prof. David Cunningham.

• Spesialisasi dalam kanker kerongkongan, lambung, pankreas, dan hati
• Menjadi ahli dalam perawatan lanjutan seperti HIPEC dan imunoterapi
• Menjadi direktur Institute for Digestive System Tumors
• Menjadi dosen di sekolah kedokteran Universitas Tel Aviv
• Menjadi anggota asosiasi onkologi dan radiologi Israel

Prof. Merimsky mengepalai Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center, yang berspesialisasi dalam kasus sarkoma kompleks.

• Lebih dari 25 tahun pengalaman di bidang onkologi
• Menjalani pelatihan fellowship di Institut Gustave Roussy di Paris
• Associate Professor di Fakultas Kedokteran Sackler
• Anggota aktif ESMO Sarcoma Faculty
• Telah mempublikasikan banyak karya ilmiah tentang pengobatan sarkoma

Profesor Arber mengepalai Pusat Pencegahan Kanker di Sourasky Medical Center (Ichilov) – salah satu rumah sakit terkemuka di Israel untuk perawatan kanker.

• Memiliki pengalaman lebih dari 30 tahun dalam mengobati tumor saluran gastrointestinal (GI)
• Memimpin studi tentang terapi gen untuk kanker saluran pencernaan dan deteksi dini kanker
• Menyelesaikan pekerjaan penelitian di NewYork-Presbyterian Center di AS
• Penulis lebih dari 300 karya ilmiah tentang onkologi gastroenterologi
• Anggota dari perkumpulan utama termasuk European Society of Digestive Oncology

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.